Inter-individual differences in cytokine release in patients undergoing cardiac surgery with cardiopulmonary bypass

Clinical and Experimental Immunology

Volumn 125, Issue 1, 2001, Pages 80-88

  Roth Isigkeit, A ^a   Hasselbach, L ^a   Ocklitz, E ^a   Bruckner S ^a   Ros, A ^a   Gehring, H ^a   Schmucker, P ^a   Rink, L ^a   Seyfarth, M ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

BAT2; Cardiac surgery; Cytokine (TNF , IL 6, IL 1 , sIL 2R) inter individual differences; Polymorphism; TNF , TNF , IL 6 gene

Indexed keywords

CYTOKINE; GENE PRODUCT; INTERLEUKIN 1; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; PROTEIN BAT2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE LOCUS; GENETIC POLYMORPHISM; GENOTYPE; HEART SURGERY; HUMAN; INFLAMMATION; INTRON; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; STRESS;

CARDIOPULMONARY BYPASS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; THORACIC SURGERY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034909142     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01521.x     Document Type: Article

References (49)

1. Mechanisms of the systemic inflammatory response
2. Inflammatory cascade. A final common pathway for perioperative injury?
3. Tumor necrosis factor-α and interleukin-1β synergistically depress human myocardial function
4. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization
5. The systemic inflammatory response to cardiopulmonary bypass: Pathophysiological, therapeutic, and pharmacological cological consideration
6. Interleukin-6 and tumour necrosis factor during cardiopulmonary bypass
7. Endocrine and molecular responses to surgical stress
8. The pathophysiology of tumor necrosis factors
9. Tumor necrosis factor-α and tumor necrosis factor-β (lymphotoxin) stimulate the production of granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and IL-1 in vivo
10. Stimulation of interleukin-6 mRNA levels by tumor necrosis factor and interleukin-1
11. Attenuation of cardiopulmonary bypass-derived inflammatory reactions reduces myocardial reperfusion injury in cardiac operations
12. Sepsis and cytokines: Current status
13. Interleukin-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release
14. Leptin and interleukin-6 in sepsis
15. Septic shock: Pathogenesis
16. Interindividual variations in cytokine levels following cardiopulmonary bypass
17. Perioperative serum levels of tumour-necrosis-factor alpha (TNF-α), IL-1β, IL-6, IL-10 and soluble IL-2 receptor in patients undergoing cardiac surgery with cardiopulmonary bypass without and with correction for haemodilution
18. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor
19. Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit
20. Higher cytotoxic activity and increased levels of IL-1β, IL-6, and TNF-α in patients undergoing cardiopulmonary bypass
21. Tumor necrosis factor gene polymorphism and septic shock in surgical infection
22. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: Relevance to disease
23. Association of TNF2, a TNF-α promoter polymorphism, with septic shock susceptibility and mortality. A multicenter study
24. Tumour necrosis factor (TNF) gene polymorphism influences TNF-α production in lipopolysaccharide (LPS) -stimulated whole blood cell culture in healthy humans
25. Cytokine production by normal human monocytes: Inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism
26. The effect of hemodilution on plasma levels of cortisol and free cortisol
27. Cytokine release and changes of peripheral blood mononuclear cells by general anaesthesia
28. A common functional polymorphism (C→A substitution at position -863) in the promoter region of the tumour necrosis factor-α (TNF-α) gene associated with reduced circulating levels of TNF-α
29. Interleukin-6 gene polymorphism and insulin sensitivity
30. The study of tumor necrosis factor beta gene polymorphism in lung cancer patients
31. A highly polymorphic microsatellite marker in the human MHC class III region, close to the BAT2 gene
32. Perioperative cytokine release during coronary artery bypass grafting in patients of different ages
33. Plasma leukaemia inhibitory factor, interleukin 6 and soluble interleukin 6 receptor levels during cardiopulmonary bypass with extracorporeal circulation
34. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity
35. Early IL-2/sIL-2R surge following surgery leads to temporary immune refractoriness
36. Changes of leukocyte subsets in coronary artery bypass surgery: Cardiopulmonary bypass versus 'off-pump' techniques
37. Alterations in the number of circulating leukocytes, phenotype of monocyte and cytokine production in patients undergoing cardiothoracic surgery
38. Changes of white blood cells, immunosuppressive acidic protein, and interleukin-2 receptor after open heart surgery
39. Circulating interleukin 6 as a useful marker for predicting postoperative complications
40. Does anaesthesia have long-term consequences?
41. TNF gene expression in monocytes of low and high responder individuals
42. Recent progress in the tumor necrosis factor-α field
43. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription
44. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha
45. Functional analysis of a new polymorphism in the human TNF alpha gene promoter
46. Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes
47. Polymorphisms in the tumor necrosis factor genes in Wegener's granulomatosis
48. Genetic association studies of tumour necrosis factor α and β and tumour necrosis factor receptor 1 and 2 polymorphisms across the clinical spectrum of multiple sclerosis
49. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis